David R D'Adamo MD

Instructor in Medicine, Dana-Farber Cancer Institute

450 Brookline AveBoston, MA 02215
Phone+1 617-632-5204
Fax+1 617-632-3408

Dr. D'Adamo is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. D'Adamo's full profile Already have an account?

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1999 - 2002
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1997 - 1999
New York University School of MedicineClass of 1997

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

NY State Medical License 1998 - 2028
MA State Medical License 2011 - 2014

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Partners Longitudinal Medical Record, Partners Healthcare System, 2013-2014

Clinical Trials

Doxorubicin Hydrochloride and Alvocidib in Treating Patients With Metastatic or Recurrent Sarcoma That Cannot Be Removed By Surgery
COMPLETED
PHASE1

Publications & Presentations

PubMed

11 citations
Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours
Robin L. Jones, Mark J. Ratain, Peter J. O'Dwyer, Lillian L. Siu, Jacek Jassem
European Journal of Cancer. 2019-10-01
13 citations
A Phase II Trial of Sorafenib and Dacarbazine for Leiomyosarcoma, Synovial Sarcoma, and Malignant Peripheral Nerve Sheath Tumors
D. R. D'Adamo, Mark A. Dickson, Mary Louise Keohan, Richard D. Carvajal, Martee L. Hensley
The Oncologist. 2019-06-01
Eribulin versus dacarbazine in patients with leiomyosarcoma: subgroup analysis from a phase 3, open-label, randomised study.
Jean-Yves Blay, Patrick Schöffski, Sebastian Bauer, Anders Krarup-Hansen, Charlotte Benson
British journal of cancer. 2019-05-09

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Similar Physicians & HCPs

Rachel Freedman, MD
OncBoston, MA
David Weinstock, MD
OncBoston, MA
Andrew Lane, MD
OncBoston, MA
Caron Jacobson, MD
OncBoston, MA
Priscilla Merriam, MD
OncBoston, MA
Jorge Castillo, MD
OncBoston, MA
Bradley McGregor, MD
OncBoston, MA
Douglas Rubinson, MD
OncBoston, MA
Matthew Davids, MD
OncBoston, MA
Matthew Yurgelun, MD
OncBoston, MA

Doximity / States / Massachusetts / Boston / David D'Adamo, MD

Dr. David D'Adamo, Dr. David D'Adamo, MD, Dr. D D'Adamo, Dr. David R D'Adamo